Selected Grants
Impact of Autonomic Dysfunction on Multi-Organ Dysfunction following Severe TBI: The AUTO-BOOST Study
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2028A Risk Stratification Model for Health and Academic Outcomes in Children with Concussion Based on Novel Symptom Trajectory Typologies
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2028RECOVER-NERUO
ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2022 - 2026Allopregnanolone in post-stroke depression
ResearchCo Investigator · Awarded by American Heart Association · 2024 - 2026Integrated Training in Anesthesiology Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1996 - 2026Duke Testing Site for Stroke Preclinical Assessment Network
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2025NINDS Research Education Programs for Residents and Fellows in Neurosurgery
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Neurological Disorders and Stroke · 2009 - 2025Mechanisms and Clinical Impact of Myocardial Injury Following Traumatic Brain Injury
ResearchCo-Mentor · Awarded by National Institutes of Health · 2019 - 2025ASSESS
ResearchPrincipal Investigator · Awarded by University of Texas - Southwestern · 2022 - 2025Phase 1b Parkinson's Disease
ResearchMedical Monitor · Awarded by Allyx Therapeutics, Inc · 2023 - 2024A Phase II Study of an ApoE mimetic peptide to reduce Postoperative Delirium, Cognitive Dysfunction after Non-Cardiac Surgery in Older Adults
Clinical TrialCo Investigator · Awarded by Alzheimer's Drug Discovery Foundation · 2018 - 2024Healthy Volunteer Study of CSF fluid and Oral Bioavailability of RR-HNK
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2024Phase I Single Ascending Dose and Multiple Ascending Dose Study of 2R,6R-Hydroxynorketamine
Clinical TrialMedical Monitor · Awarded by National Institutes of Health · 2018 - 2024Data-driven Approaches to Healthcare Provider Resilience & Burnout during COVID-19
Clinical TrialCo Investigator · Awarded by Department of Defense · 2021 - 2023Effects of rGDF11 on Functional Recovery Following Traumatic Brain Injury (TBI) in Mice
ResearchPrincipal Investigator · Awarded by Elevian, Inc · 2021 - 2022Treating Pain in Fibromyalgia
Clinical TrialPrincipal Investigator · Awarded by Sana · 2020 - 2022Learning to Predict Delayed Cerebral Ischemia with Novel Continuous Cerebral Arterial State Index
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2021Integrate Dynamic System Model and Machine Learning for Calibration-Free Noninvasive ICP
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2021AKL-T01 ADHD Adjunctive
Clinical TrialPrincipal Investigator · Awarded by Akili Interactive Labs, Inc. · 2018 - 2021Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2021Developing Biomarkers for Traumatic Brain Injury and Alzheimer's Disease via Acoustic Exosome Separation Devices
ResearchCo Investigator · Awarded by United States Army Medical Research Acquisition Activity · 2018 - 2021A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke
Clinical TrialPrincipal Investigator · Awarded by ReNeuron Group plc · 2017 - 2021rGDF11 improves outcomes after closed head injury and intracranial hemorrhage
ResearchPrincipal Investigator · Awarded by Elevian, Inc · 2019 - 2020CN105 to improve long-term recovery in models of intracerebral hemorrhage
ResearchCo Investigator · Awarded by AegisCN LLC · 2018 - 2020MicroRNA Profiling to Characterize and Predict Posttraumatic Epilepsy following Traumatic Brain Injury
ResearchCo Investigator · Awarded by Department of Defense · 2018 - 2020Proteo improves outcomes after closed head injury and subarachnoid hemorrhage
ResearchPrincipal Investigator · Awarded by Prostasis, LLC · 2019 - 2020Extract of Erigeron breviscapus protects against brain injury in stroke
ResearchCo Investigator · Awarded by Yunnan Biovalley Pharmaceutical Co., Ltd · 2017 - 2020Immunological biomarker studies in myasthenia gravis
Clinical TrialCo-Mentor · Awarded by National Institutes of Health · 2014 - 2020A Phase 1b MAD Study of TT301/MW189
Clinical TrialCo Investigator · Awarded by University of Kentucky · 2017 - 2019PDE-1 Inhibitor Study- LOI
Clinical TrialPrincipal Investigator · Awarded by Intra-Cellular Therapies, Inc. · 2017 - 2019Prophylactic administration of CN-105 confers neuroprotection against acute brain injury
ResearchPrincipal Investigator · Awarded by Department of Defense · 2016 - 2018Xenon As A Therapeutic in Experimental Intracerebral Hemorrhage
ResearchSignificant Contributor · Awarded by National Institutes of Health · 2015 - 2018Training for the Prevention and Treatment of Stroke in China
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2017Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification
ResearchFaculty Member · Awarded by Food and Drug Administration · 2013 - 2016Neuroprotective pentapeptide improves outcome after ischemic stroke and subarachnoid hemorrhage
FellowshipPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2014 - 2016Linearized apoE peptide mimetic is neuroprotective in acute cerebrovascular disease
FellowshipPrincipal Investigator · Awarded by American Heart Association · 2014 - 2016Karyopharm Theapeutics Clinipace Project
ResearchInvestigator · Awarded by Karyopharm Therapeutics · 2014 - 2015Eythropotien Peptides & Traumatic Brain Injury
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2013 - 2015Multidisciplinary Neonatal Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2015A Multicenter, Double-Blind, Placedbo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG0002) on reducing Infarct volume in Acute Ischemic Stroke.
Clinical TrialPrincipal Investigator · Awarded by Biogen Idec Inc. · 2013 - 2015pH dependent neuroprotective agents improve outcome in murine SAH
ResearchPrincipal Investigator · Awarded by NeurOp Inc · 2013 - 2014IPA- Hana Dawson
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2012 - 2013PeriOperative Interventional Neuroprotection Trial POINT
ResearchCo Investigator · Awarded by National Institutes of Health · 2001 - 2008Triple transgenic model of Alzheimer's Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2007Genetics, Inflammation & Post-op Cognitive Dysfunction
ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 2006ApoE-mimetic peptides protect against brain injury
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2005Microglial Neuron Specific Toxin
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004Apolipoprotein E effecton the CNS immune response.
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2003Apolipoprotein E effect on the CNS immune response
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2003The Effect Of Apoe On Cholinergic Neuron Survival
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2001same
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2001External Relationships
- Aegis, LLC
- Annovis Bio
- Immunochem
- NeurOp
- NeuroLogic Consulting, LLC
- Shinkei Therapeutics
- Zenith Insurance
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.